PhD neuroscientist building precision neurotechnology for psychedelic-assisted therapy. Founder @ Psio + NeuroRecovery | TEDx Speaker
Boulder, CO
Joined December 2020
- Tweets612
- Following1.4K
- Followers2.8K
- Likes3.9K
Pinned Tweet
My TEDx talk is live! I share my path from TBI to heroin addiction to neuroscientist, along with simple strategies for resilience and top-down control. I’d truly appreciate you sharing it.
youtube.com/watch?v=08LgirAD…
Devin Effinger, PhD retweeted
Our first Deep Dive of 2026 covers a recent Perspective calling for recognizing and removing the barriers faced by researchers with lived experience of mental illness or SUDs who work in our field.
By @UmaRChatterjee, @SchumerMaya, @devin_effinger & colleagues.
youtu.be/y5fymczeNFc
Devin Effinger, PhD retweeted
Postdoctoral fellowship available in structure guided drug discovery in @RothLabUNC
Please RT
Devin Effinger, PhD retweeted
Researchers with lived experience of mental illness or SUDs bring vital expertise & insight to our field, yet remain underrepresented and face barriers to participation and leadership.
This Perspective from @UmaRChatterjee, @SchumerMaya, @devin_effinger, @viscidula, @noelvest, Michael Cahill, @BStaglin, @EricJNestler calls for breaking these barriers and proposes actionable strategies to build more inclusive environments by reforming admissions, mentorship, and leadership pathways.
nature.com/articles/s44277-0…
Devin Effinger, PhD retweeted
🚨 Please RT!
We’re recruiting a motivated postdoc to dissect the neurocircuits of affective pain.
Expertise in behavioral models of pain/SUDs, stereotaxy, microscopy, opto/chemogenetics, or fiber photometry encouraged.
Apply 👉 recruit.apo.ucla.edu/JPF1064…
#Neuroscience #Postdoc
If anyone is looking (or know of someone) for a roommate and has a spot at the Atlantis for @ACNPorg , please let me know!
Devin Effinger, PhD retweeted
Devin Effinger @devin_effinger and @MelissaHerman4 argue that, though many human psychedelic clinical trials are underway, preclinical studies remain our best bet to answer fundamental questions about the neurobiology of psychedelics.
thetransmitter.org/psychedel…
What an honor! Humbled and grateful. It was a beautiful disaster and a perfect metaphor for my recovery ending with a standing ovation. Thank you so much to the organizers and stay tuned for the link! @TEDxBoulder
🚨 New paper 🚨
For years, there has been concern that psychedelics might pose cardiovascular risks due to their agonist activity at the 5-HT2B receptor — the same target linked to drug-induced heart disease.
pubs.acs.org/doi/full/10.102…
Pharmacokinetic modeling gave us a potential explanation:
👉 Fenfluramine is still present in blood at 24h, leading to sustained and chronic 5-HT2B activation.
👉 Low doses of LSD and psilocin are both off the receptor within 8-10h.
Devin Effinger, PhD retweeted
@ACNPorg brought @UmaRChatterjee
@devin_effinger & me together last year: After finding each other on X-as we are all public/open about our lived experience -we met and discussed the ideas for this Study Group! Looking forward to doing this work together@ #ACNP2026🧠❤️💥‼️
THRILLED to share @ACNPorg news x2!
1) Our study group—“Centering Lived Experience in Psychiatric Neuroscience Research: Challenges, Opportunities, & Calls to Action” @EricJNestler @BStaglin @SchumerMaya @devin_effinger @viscidula @noelvest @MichaelECahill1=ACCEPTED! 🤩#ACNP2026
Devin Effinger, PhD retweeted
THRILLED to share @ACNPorg news x2!
1) Our study group—“Centering Lived Experience in Psychiatric Neuroscience Research: Challenges, Opportunities, & Calls to Action” @EricJNestler @BStaglin @SchumerMaya @devin_effinger @viscidula @noelvest @MichaelECahill1=ACCEPTED! 🤩#ACNP2026
It’s wild how much change is possible in this life. From relearning to talk post-TBI, to full blown heroin addiction, to a life beyond anything I could have imagined. Im very fortunate to not only be alive, but to have been selected to speak at 2025 TEDxBoulder!
Devin Effinger, PhD retweeted
🚨 New preprint alert!
Intranasal esketamine helps with treatment-resistant depression—but do sex differences shape who responds best, and how?
We analyzed 5 RCTs and found striking sex-specific symptom patterns.
👉 medrxiv.org/content/10.1101/…
#Depression #Esketamine
The inaugural #GRCPsychedelics was a success! I am honored to have been one of a few chosen to receive a travel award and be able to share the stage with the leaders in the field. Very grateful to the organizers. 🙏 @kwanalexc @VVyazovskiy @MelissaHerman4 @ViditaVaidya
Devin Effinger, PhD retweeted
Save the date for Psychedelics GRC ***2029***!!
We worked so well as a team for the #GRCPsychedelics @VVyazovskiy @MelissaHerman4 @ViditaVaidya
and congrats to @TheBorisLab and @MikaelPalner, who will be the future vice-chairs!
